For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Pharmakea, Inc.

USPTO Granted Patents = 19

% Expired Patents = 21.1

EPO Patents = 6

Forward Citations = 60

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

John Howard Hutchinson (15 out of 112 patents)

Martin W Rowbottom (12 out of 41 patents)

David Gregory Lonergan (11 out of 21 patents)

4. Imelda Calderon (4 out of 12 patents)

5. Kevin Ross Holme (2 out of 6 patents)

6. Jillian Frances Evans (2 out of 9 patents)

7. Timothy Andrew Parr (2 out of 12 patents)

8. Kevin Duane Bunker (1 out of 45 patents)

9. Gretchen Bain (1 out of 3 patents)

10. Fei Huang (1 out of 1 patent)

11. Andiliy Gokching Lai (1 out of 19 patents)

12. Deidre A MacKenna (1 out of 7 patents)

13. Deidre A Mackenna (0 patent)

19 patents: Sort by Forward Citations

1. 11793797 - Uses of a lysyl oxidase-like 2 inhibitor (2023-10-24),

2. 11459309 - Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making (2022-10-04),

3. 11358936 - Lysyl oxidase-like 2 inhibitors and uses thereof (2022-06-14),

4. 11345676 - Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds (2022-05-31),

5. 11072585 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2021-07-27),

6. 11058676 - Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof (2021-07-13),

7. 10774069 - Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making (2020-09-15),

8. 10766860 - Lysyl oxidase-like 2 inhibitors and uses thereof (2020-09-08),

9. 10588900 - Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof (2020-03-17),

10. 10570094 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2020-02-25),

11. 10150732 - Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof (2018-12-11),

12. 9999615 - Autotaxin inhibitor compounds (2018-06-19),

13. 9951026 - Heterocyclic vinyl autotaxin inhibitor compounds (2018-04-24),

14. 9926318 - Tetracyclic autotaxin inhibitors (2018-03-27),

15. 9850203 - Autotaxin inhibitor compounds (2017-12-26),

PharmAkea, Inc. is a biopharmaceutical company that specializes in the discovery and development of small molecule drugs. We focus on the treatment of diseases in the fields of fibrosis, inflammation, and immuno-oncology. With a unique approach to drug discovery and a team of experienced scientists, we strive to bring innovative therapies to patients in need. Visit our website to learn more about our pipeline, scientific approach, and ongoing research projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Pharmakea, Inc.

19 Patents

#313 in San Diego, CA

#4,094 in California

#17,113 in US

#32,592 in the World

San Diego, CA, United States of America

Pharmakea, Inc.

Forward Citations = 60

13 inventors:

John Howard Hutchinson (15 out of 112 patents)

Martin W Rowbottom (12 out of 41 patents)

David Gregory Lonergan (11 out of 21 patents)

4. Imelda Calderon (4 out of 12 patents)

5. Kevin Ross Holme (2 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…